Established in late 2020, we are the first clinical psychedelic lab in Australia. Standing on the shoulders of giants overseas, and alongside a small handful of local researchers and clinicians, we are helping to establish the field of clinical psychedelics in Australia. The lab is focused on developing a rigorous program of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms. To follow our progress and stay up to date with announcements about our exciting projects, please like this page, check out our lab website, and/or follow our lab head, Dr. Paul Liknaitzky on Twitter. https://www.monash.edu/turner-institute/paul-liknaitzky-lab https://twitter.com/PLiknaitzky/